Deutsche Bank
SLDB icon

Deutsche Bank’s Solid Biosciences SLDB Stock Holding History

Deutsche Bank’s Portfolio SLDB Stock Details SLDB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$775K Buy
77,542
+31,267
+68% +$237K ﹤0.01% 2522
2026
Q1 		$333K Buy
46,275
+6,313
+16% +$40.6K ﹤0.01% 2781
2025
Q4 		$225K Sell
39,962
-12,198
-23% -$66.1K ﹤0.01% 2959
2025
Q3 		$322K Buy
52,160
+6,575
+14% +$38.4K ﹤0.01% 2801
2025
Q2 		$222K Buy
45,585
+30,659
+205% +$108K ﹤0.01% 2902
2025
Q1 		$55.2K Sell
14,926
-1,376
-8% -$5.89K ﹤0.01% 3361
2024
Q4 		$65.2K Buy
16,302
+1,376
+9% +$7.56K ﹤0.01% 3378
2024
Q3 		$104K Hold
14,926
– – ﹤0.01% 3207
2024
Q2 		$84.6K Buy
+14,926
New +$134K ﹤0.01% 3169
2022
Q2 		– Sell
-2,158
Closed -$39K – 4303
2022
Q1 		$39K Sell
2,158
-256
-11% -$4.52K ﹤0.01% 3911
2021
Q4 		$63K Buy
2,414
+127
+6% +$3.88K ﹤0.01% 3886
2021
Q3 		$82K Sell
2,287
-3,660
-62% -$155K ﹤0.01% 3968
2021
Q2 		$327K Buy
5,947
+4,620
+348% +$305K ﹤0.01% 3492
2021
Q1 		$110K Sell
1,327
-73
-5% -$8.08K ﹤0.01% 3924
2020
Q4 		$160K Buy
1,400
+477
+52% +$30.2K ﹤0.01% 3591
2020
Q3 		$29K Buy
923
+79
+9% +$3.03K ﹤0.01% 4057
2020
Q2 		$37K Sell
844
-7,869
-90% -$327K ﹤0.01% 3937
2020
Q1 		$312K Sell
8,713
-3,072
-26% -$152K ﹤0.01% 2727
2019
Q4 		$786K Sell
11,785
-2,156
-15% -$238K ﹤0.01% 2494
2019
Q3 		$2.16M Sell
13,941
-20,830
-60% -$2.36M ﹤0.01% 1862
2019
Q2 		$3M Buy
34,771
+8,223
+31% +$897K ﹤0.01% 2129
2019
Q1 		$3.66M Buy
26,548
+26,159
+6,725% +$6.55M ﹤0.01% 2065
2018
Q4 		$154K Sell
389
-1,463
-79% -$688K ﹤0.01% 4009
2018
Q3 		$1.31M Buy
1,852
+658
+55% +$413K ﹤0.01% 3123
2018
Q2 		$639K Buy
1,194
+408
+52% +$126K ﹤0.01% 3713
2018
Q1 		$87K Buy
+786
New +$265K ﹤0.01% 4562

Other funds holding SLDB

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Deutsche Bank's SLDB Position: Q2 2026 in Review

Deutsche Bank increased its Solid Biosciences (SLDB) stake by 68% in Q2 2026, buying an estimated $237K and bringing the position to 77,542 shares worth $775K. The position accounts for ﹤0.01% of the portfolio, ranked #2522.

Deutsche Bank first reported a position in SLDB in Q1 2018 and has held it in 26 quarters since. The position peaked at $3.66M in Q1 2019. 157 funds tracked by Wall St. Rank hold SLDB as of Q2 2026.

  • Deutsche Bank held 77,542 shares of Solid Biosciences worth $775K as of Q2 2026.
  • Deutsche Bank bought 31,267 Solid Biosciences shares in Q2 2026, an estimated $237K.
  • Solid Biosciences made up ﹤0.01% of Deutsche Bank's portfolio in Q2 2026, its #2522 holding.
  • Deutsche Bank first reported a position in Solid Biosciences in Q1 2018 and has held it in 26 quarters since.
  • Deutsche Bank's Solid Biosciences position peaked at $3.66M in Q1 2019.
  • 157 funds tracked by Wall St. Rank held Solid Biosciences as of Q2 2026.

Based on Deutsche Bank's 13F filing for Q2 2026, filed 7 Aug 2026.